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A functional metagenomics based approach exploiting the microbiota of suppressive soils from an organic ﬁeld site
has succeeded in the identiﬁcation of a clone with the ability to inhibit the growth of Bacillus subtilis DSM10.
Sequencing of the fosmid identiﬁed a putative b-lactamase-like gene abgT. Transposon mutagenesis of the abgT gene
resulted in a loss in ability to inhibit the growth of B. subtilis DSM10. Further analysis of the deduced amino acid
sequence of AbgT revealed moderate homology to esterases, suggesting that the protein may possess hydrolytic
activity. Weak lipolytic activity was detected; however the clone did not appear to produce any b-lactamase activity.
Phylogenetic analysis revealed the protein is a member of the family VIII group of lipase/esterases and clusters with a
number of proteins of metagenomic origin. The abgT gene was sub-cloned into a protein expression vector and when
introduced into the abgT transposon mutant clones restored the ability of the clones to inhibit the growth of B. subtilis
DSM10, clearly indicating that the abgT gene is involved in the antibacterial activity. While the precise role of this
protein has yet to fully elucidated, it may be involved in the generation of free fatty acid with antibacterial properties.
Thus functional metagenomic approaches continue to provide a signiﬁcant resource for the discovery of novel
functional proteins and it is clear that hydrolytic enzymes, such as AbgT, may be a potential source for the development
of future antimicrobial therapies.
Introduction
In recent years, metagenomic approaches have increasingly been
employed to access the uncultured and uncultivable majority of
microorganisms present in the environment, which is estimated to
be more than 99% of the existing prokaryotes in soil systems.1
Metagenomic analyses, such as large-scale shotgun sequencing,
have to date been applied to various environments and have led to
the discovery of novel species, and even the elucidation of novel
pathways and community-specific metabolism.2-7 Apart from
sequencing-based approaches, metagenomic libraries can also be
screened for the presence and expression of specific functions and
activities, also known as gain-of-function, and a range of novel
biocatalysts, many with potential industrial applications, as well as
small molecules with novel bioactivities, have already been discov-
ered using such functional metagenomics based techniques.8-16
With its extremely high, but still largely underexplored and
unexploited, microbial diversity and abundance, soil is one of the
richest potential sources for novel biocatalysts and novel natural
products.17-20 In recent years, functional metagenomic analyses
has led to the discovery of a wide range of enzymes and bioactive
metabolites, e.g. antimicrobial agents, from the soil microbiota.21-
23 Soils that suppress plant disease, or so called suppressive soils,
are known to exert their antagonistic function through their soil
microbiota;24 particularly through the presence of phytopatho-
genic antagonistic (antibiotic) activity.25 Indeed it has recently
been reported that upon attack by fungal pathogens plants exploit
the microbial consortia from soil to protect themselves against
infection.26 Thus suppressive soils which show a natural suppres-
sion of growth of certain plant pathogens are likely to be a valu-
able source for the discovery of novel bioactive compounds.
Metagenomic approaches have also been employed to assess
the bacterial natural product biosynthetic diversity of different
soil microbial communities.27 From this work it appears that
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prokaryotic natural product biosynthesis biodiversity is poten-
tially much larger than we have previously thought from culture
dependent based approaches. Indeed a wide variety of natural
products including indigo, indirubin,28,29 turbomycin A, turbo-
mycin B,30 violacein,31 palmitoylputrescine,32 norcardamine,
terragines A-E33 and tetarimycin A34 among others, have in the
past been isolated from environmentally derived metagenomic
libraries. In addition with the advent of improved heterologous
host expression systems in Streptomyces spp., in different Proteo-
bacteria such as Agrobacterium tumefaciens, Escherichia coli, Cau-
lobacter vibrioides, Pseudomonas putida, Burkholderia graminis
and Ralstonia metallidurans and in Saccharomyces cerevisiae,18,35-
37 an increasing number of bioactive small molecules with poten-
tial biopharmaceutical applications are being discovered on an
on-going basis. Examples include the pentacyclic polyketide erda-
cin,35 the fluostatins36 the antitumor substance BE-54017,14 the
indolotryptoline antiproliferative agent (borregomycin A) and
the dihydroxyindolocarbazole anticancer/antibiotics (borregomy-
cins B-D)38 together with the antibiotics fasamycins A and B.39
Thus given the potential of suppressive soils containing
microbiota with antimicrobial and anti-phytopathogenic activi-
ties, we employed a functional metagenomics-based approach in
an effort to identify novel antibiotic activities from the micro-
biome of soils from an organic field site. This approach resulted
in the cloning of a b-lactamase-like gene, abgT, with an ability to
inhibit the growth of B. subtilis DSM10.
Results
Screening of the soil library
Approximately 14000 clones were screened for antimicrobial
activity against Pseudomonas aeruginosa PA01 and Bacillus subtilis
DSM10, and a single clone, TO-T-020-P12, was found to clearly
inhibit the growth of B. subtilis DSM10 (Fig. 1). This clone was
subjected to further analysis and was found to consistently pro-
duce a zone of inhibition against B. subtilis DSM10 in overlay
assays. The clone did not, however, appear to have the ability to
inhibit P. aeruginosa PA01. Furthermore the clone TO-T-020-
P12 did not inhibit growth of B. subtilis DSM10 in the absence
of arabinose, which was responsible for inducing fosmid replica-
tion to multiple copy numbers. The TO-T-020-P12 fosmid was
isolated and a fresh stock of E. coli EPI300TM T1 cells was re-
transformed with the fosmid and activity was confirmed. E. coli
EPI300TM T1 clones containing pCC1FOS with the fosmid con-
trol DNA supplied with the library production kit were used as a
negative control and consistently failed to produce any activity
against either B. subtilis DSM10 or P. aeruginosa PA01.
Sequencing and annotation of fosmid
The TO-T-020-P12 fosmid was sequenced by Roche 454 pyro-
sequencing, and assembly of the resulting sequences produced a
contig of 42137 bp, with a G-C content of 60.5%. Further exami-
nation of the sequence for vector contamination yielded an insert
size of 35277 bp (GenBank accession no. JX846920). The insert
sequence was analyzed for putative ORFs using both the FGE-
NESB and the MetaGene programmes. While each program pre-
dicted a slightly different number of ORFs, in general there was
substantial agreement between the main ORFs present (Table S1).
Each ORF was putatively annotated using blastP searches for
homologous proteins and the predicted annotations were further
refined by manual examination with the final annotation selected
based on evidence that the proteins appeared to be a better fit and
more closely-related. A total of 27 ORFs were putatively annotated
(Table 1, Fig. 2). The genes appeared to encode for a range of pro-
teins with potentially diverse functions including proteins involved
in hydrolysis, oxidation/reduction, biosynthesis, membrane trans-
port, transcriptional regulation and a number of proteins of as yet
unknown function. The putative annotations for each ORF listed
in Table 1 reflect the top matches after blastP searches. The vast
majority of the species associated with these proteins appear to be
environmental isolates, particularly from soil and aquatic habitats,
and include members of the following bacterial phyla; Proteobacte-
ria, Firmicutes, Acidobacteria, Bacteroidetes and Verrucomicrobia. A
number of the putative ORFs were found to be associated with the
bacterium Ellin514, with 4 adjacent putative proteins (Genes 9–
12) appearing to share homology with proteins from this bacte-
rium. This strain, also known as Pedosphaera parvula Ellin514, is
an obligate aerobic bacterium, which was isolated from pasture soil
in Victoria, Australia, and belongs to the Verrucomicrobia phylum
whose members are common in terrestrial environments.40
Attempts were made to further determine the phylogenetic origin
of the metagenomic DNA using MEGAN, however the results did
not predict any taxonomic origin below the Proteobacteria phylum
level, and with only 32% of the ORFs assigned to this phylum it is
difficult to postulate more precisely the origin of the metagenomic
DNA in clone TO-T-020-P12.
Transposon mutagenesis and identification of insertion site
Two mutants, TO-T-020- P12 E2 and TO-T-020-P12 F2,
were obtained following screening of transposon mutants which
Figure 1. Screening of the soil metagenomic library. Metagenomic
clones were overlaid with soft agar containing B. subtilis DSM10. Arrow
indicates clone TO-T 020 P12 producing a zone of growth inhibition.
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had lost the ability to inhibit growth of B. subtilis DSM10. The
transposon insertion sites were determined by bidirectional
sequencing and both mutants were found to have insertions at the
30 end of ORF 26 approximately 55 bp from the stop codon. Puta-
tive annotation of the fosmid revealed that ORF 26 showed similar-
ity to a b-lactamase protein (1). This ORF was subsequently
designated as gene abgT and the results indicated that transcription
of this gene had been disrupted and therefore that it was potentially
playing a role in the observed antibacterial activity.
Analysis of the abgT gene
The abgT gene which is 1335 bp yields a predicted protein of 444
amino acids, with a molecular mass of 47.2 kDa. The protein has a
theoretical pI of 9.22 and an instability index of 30.65, suggesting
that it is a stable protein. TheORF is located toward the 30 end of the
insert sequence and is adjacent
to a partial ORF with similar-
ity to a pyruvate/2-oxogluta-
rate dehydrogenase (Fig. 2).
The gene appears to have a
GTG start codon with an
almost perfect Shine-Delgarno
consensus sequence located
6 bp upstream. Analysis of the
promoter region suggests that
Table 1. Putative annotation of the open reading frames from fosmid TO-T 020 P12
ORF Strand Length (aa) Putative Proteins % Coverage / Identity E value Accession No.
1* ¡ 434 hypothetical protein Lcho_1379 [Leptothrix cholodnii SP-6] 98/32 1e-34 YP_001790412.1
2 C 413 hypothetical protein Mettu_3900 [Methylobacter tundripaludum
SV96]
78/41 4e-82 ZP_08782479.1
3 C 296 glucose-1-phosphate thymidylyltransferase [Leptothrix cholodnii
SP-6]
97/81 9eC172 YP_001789661.1
4 C 291 type 11 methyltransferase [Candidatus Desulforudis audaxviator
MP104C]
56/33 8e-10 YP_001717291.1
5 C 483 polysaccharide biosynthesis protein [Beggiatoa sp PS] 95/32 1e-69 ZP_01999860.1
6 C 234 transferase hexapeptide repeat containing protein [Pelosinus
fermentans JBW45]
82/43 3e-51 EIW47873.1
7 C 97 hypothetical protein [Anaeromyxobacter spFw109–5] 77/40 4e-12 YP_001378438.1
8 C 532 AMP-dependent synthetase/ligase [Paracoccus denitriﬁcans
PD1222]
97/46 2e-146 YP_915093.1
9 C 308 eight transmembrane protein EpsH [bacterium Ellin514] 88/44 1e-61 ZP_03627452.1
10 C 665 multi-sensor signal transduction histidine kinase [bacterium
Ellin514]
99/45 0eC00 ZP_03627457.1
11 C 456 two component, sigma54 speciﬁc, transcriptional regulator, Fis
family [bacterium Ellin514]
98/68 0eC00 ZP_03627458.1
12 ¡ 210 2-deoxy-D-gluconate-3-dehydrogenase [bacterium Ellin514] 99/29 2e-04 ZP_03627456.1
13 ¡ 755 TPR repeat-containing protein [uncultured bacterium 92] 96/45 0eC00 ADC35860.1
14 ¡ 293 hypothetical protein Cyan7822_3123 [Cyanothece spPCC 7822] 82/41 4e-57 YP_003888352.1
15 ¡ 230 HAD family hydrolase [Geobacter lovleyi SZ] 93/39 2e-42 YP_001951850.1
16 ¡ 204 hypothetical protein HFX_2454 [Haloferax mediterranei ATCC
33500]
85/43 3e-39 YP_006350126.1
17 ¡ 588 acyl-CoA dehydrogenase [Carboxydothermus hydrogenoformans
Z-2901]
98/49 0eC00 YP_360435.1
18 C 167 DinB family protein [Solitalea canadensis DSM 3403] 94/37 9e-25 YP_006254353.1
19 ¡ 390 3-ketoacyl-CoA thiolase [Candidatus Chloracidobacterium
thermophilum B]
99/69 0eC00 YP_004862742.1
20 ¡ 213 a/b hydrolase [Coxiella burnetii RSA 493] 92/41 5e-48 NP_820749.1
21 ¡ 270 a/b hydrolase [Rubrobacter xylanophilus DSM 9941] 87/31 1e-13 YP_642926.1
22 ¡ 766 3-hydroxyacyl-CoA dehydrogenase [Candidatus
Chloracidobacterium thermophilum B]
99/48 0eC00 YP_004862740.1
23 ¡ 267 ABC-2 type transporter [Chloroﬂexus aurantiacus J-10-ﬂ] 99/33 4e-33 YP_001633913.1
24 ¡ 330 ABC transporter-like protein [Roseiﬂexus castenholzii DSM 13941] 91/48 6e-79 YP_001430568.1
25 ¡ 346 hypothetical protein [Desulfosporosinus meridiei DSM 13257] 52/31 1e-04 YP_006621226.1
26 ¡ 444 b-lactamase [Turneriella parva DSM 21527] 86/55 2e-137 YP_006439821.1




Figure 2. Schematic representation of putative open reading frames. Putative open reading frames were identiﬁed
in the 35277 bp DNA insert of fosmid clone TO-T-020-P12. The arrows represent the position and direction of tran-
scription of each open reading. The numbers correspond to the ORFs listed in Table 1. The abgT gene (ORF 26
-Table 1) is highlighted in a darker color . Arrows containing * represent partial open reading frames.
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this genemay be under the control of its own promoter, with putative
-10 (tggcatact) and -35 (gtgtcg) regions beginning 226 bp upstream
from the proposed start codon. Further analysis of the protein
revealed a potential signal peptide of 25 amino acids (VTAANSLS-
RILLALALGVTPHVAQA), suggesting that the protein may be
secreted. The predicted amino acid sequence of the AbgT protein
contains a b-lactamase conserved domain (pfam00144) and has
highest identity, of up to 55%, to several proteins classified as puta-
tive b-lactamases, with highest identity to a b-lactamase from Turn-
eriella parvaDSM 21527. Alignments of the AbgT protein sequence
with otherb-lactamase like proteins, Class Cb-lactamases and repre-
sentative of the different lipase family groups was performed and sub-
sequent phylogenetic analyses revealed that AbgT is a member of the
family VIII group of lipases/esterases (Fig. 3).41,42 This group con-
tains the Class C b-lactamases and a number ofb-lactamase like pro-
teins, though the exact function of many of these proteins has yet to
be biochemically determined.
Lipase and b-lactamase activities
To determine if the protein possessed any potential lipase
activity the original clone TO-T- 020-P12 and Tn5 mutant TO-
T-020-P12 E2 were incubated on plates containing 1% tribu-
tyrin. Clone TO-T-020-P12 produced lipolytic activity
(Fig. 4A), though the observed activity was quite weak compared
to a metagenomic lipase clone which had previously been isolated
in our laboratory and determined to have high levels of activity.13
Transcriptional disruption of the abgT gene resulted in a loss of
lipolytic activity as the mutant strain TO-T-020-P12 E2 failed to
produce any zone of clearing on tributyrin, even after prolonged
incubation. As the protein displayed similarity to b-lactamase
type proteins the chromogenic nitrocefin assay was used to deter-
mine if there was any significant b-lactamase activity present.
Both the original clone TO-T-020-P12 and the mutants TO-T-
020-P12 E2 and TO-T-020-P12 F2 were tested for activity,
using ampicillin resistant cells as a positive control. Cells contain-
ing ampicillin resistance genes produced a red color when tested
with the nitrocefin as expected. However, the metagenomic
clones failed to produce a similar reaction under the conditions
tested and therefore it was concluded that AbgT does not possess
true b-lactamase activity (Figure S1). The overlay assays with B.
subtilis DSM10 were also performed in conjugation with the
nitrocefin assay to confirm that antibacterial activity was observed
as expected under the
growth conditions used.
Restoration of
antibacterial activity in the
abgT disrupted mutants
To confirm that the b-lac-
tamase-like gene was indeed
involved in the observed anti-
bacterial activity the abgT
gene was cloned into the
expression vector pBadMyc-
HisA to create pBadMyc-
HisA-AB-RH1. The original
clone TO-T 020 P12 and
both mutants TO-T-020-P12
E2 and TO-T 020 P12 F2
were transformed with the
recombinant vector and the
clones were subsequently over-
laid with B. subtilis DSM10
(Figure 4B). The clone TO-
T-020-P12 showed clear abil-
ity to inhibit the growth of B.
subtilis DSM10, but as the
results indicate when the abgT
gene was disrupted in the TO-
T-020-P12 E2 and TO-T-
020-P12 F2 mutants both
were unable to inhibit the
growth of B. subtilis DSM10
strain (Figure 4B; 2 and 3).
However, complementation
of the TO-T-020-P12 E2 and
TO-T-020-P12 F2 mutants
Figure 3. Phylogenetic analysis of the deduced AbgT amino acid sequence. The tree contains proteins closely
related to AbgT, putative b-lactamases, Class C b-lactamases and lipase family members. The tree represents the
Family VIII lipase cluster and is rooted to the other lipase family groups.
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with the vector borne abgT restored the ability of each mutant to
inhibit growth (Figure 4B; 5 and 6). As a control, each strain was
also transformed with the pBadMyc-HisA vector lacking an insert
and the presence of the vector did not affect the inability of the
mutants to inhibit B. subtilis DSM10 growth. Thus the abgT gene
product is clearly responsible for the observed anti- B. subtilis
DSM10 activity. To confirm that a protein of the correct size was
being produced from the expression vector theHis-tagged AbgT pro-
tein was purified from the total soluble protein fraction of cell lysate
derived from arabinose induced E. coli EPI300TM T1 cells containing
pBadMyc-HisA-AB-RH1. Staining of the SDS-PAGE gel revealed a
protein with a mass just below 50kDa, which correlates well with the
predicted in silicomolecular mass of AbgT (Fig. 5).
Discussion
We report here on the cloning of the abgT gene, isolated fol-
lowing the functional screening of a soil metagenomic library;
the product of which clearly inhibits the growth of B. subtilis
DSM10. The AbgT protein while not possessing any b-lactamase
activity itself was found to possess a high level of identity with
several putative b-lacta-
mases, with highest identity
to a b-lactamase from Turn-
eriella parva DSM 21527.
Strains of T. parva have pre-
viously been isolated from
contaminated culture
medium, tap water and from
the uterus of a sow.43 AbgT
also displayed similarity to a









with the marine sponge
Cymbastela concertrica has
identified a novel antibacte-
rial protein, Abg 2, which
appears to also have similar
characteristics to the AbgT




domains and show similarity
to the same proteins in the
SwissProt database (Table 2).
Despite these similarities
there was only moderate
pairwise homology (33%) between these 2 proteins at the amino
acid level. In addition the predicted AbgT protein sequence dis-
played a weak similarity to some lipase/esterase enzymes includ-
ing a lipase/esterase from Hydrogenophaga sp. PBC and a putative
esterase from Methylomicrobium alcaliphilum. Furthermore anal-
ysis of the predicted AbgT protein sequence using the SwissProt
database suggested a protein that potentially possessed hydrolytic
activity (Table 2). The protein showed modest homology to an
esterase from Burkholderia gladioli and to the YfeW protein from
E. coli and Salmonella species and appears to be similar to type C
b-lactamases, which share sequence characteristics with members
of the group VIII family of lipases. Recent work in our laboratory
has identified a halo-tolerant lipase from the metagenome of a
marine sponge which also belongs to this group.13 Members of
this group are known to possess a conserved S-X-X-K amino acid
motif in their active site, with a conserved Y amino acid down-
stream, and analysis of the AbgT protein sequence revealed that
it too contains such conserved regions (Fig. 6) and shows similar-
ity to EstB from Burkholderia gladioli, an esterase which also con-
tains a b-lactamase fold. No significant b-lactamase activity was
detected for this protein and yet catalytic activity was shown to
be located within the conserved b-lactamase S-X-X-K motif.45,46
Figure 4. Lipolytic and antibacterial activity of the abgT gene. (A) Clone TO-T-020-P12 produced weak lipolytic
activity on agar plates containing 1% tributyrin. When the abgT gene was disrupted by Tn5 insertion in TO-T 020
P12 E2 lipolytic activity was lost. Metagenomic lipase Lpc53E1 was previously characterized in our laboratory and
was used for comparison of lipolytic activity. (B) Random mutagenesis of fosmid TO-T 020 P12 produced 2 mutants
unable to inhibit the growth of B. subtilis DSM10. Both mutants regained the ability to inhibit growth after comple-
mentation of the disrupted abgT gene. (1) TO-T- 020-P12 (2) TO-T-020-P12 E2 (3) TO-T-020-P12 F2 (4) TO-T-020-P12
with pBadMyc-HisA-AB-RH1 (5) TO-T-020-P12 E2 with pBadMyc-HisA-AB-RH1 (6) TO-T-020-P12 F2 with pBadMyc-
HisA-AB-RH1.
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We therefore suggest that the AbgT protein may produce hydro-
lytic activity mediated around the S-X-X-K catalytic site. Fur-
thermore, a protein secreted by the accessory glands of the female
sand-fly Phlebotomus papatasi has been shown to have both
lipase-like activity and antibacterial activity against both Gram-
positive and Gram-negative bacteria.47
While the exact mechanism by which AbgT produces the
observed effects remains to be elucidated it is tempting to specu-
late that hydrolytic activity may lead to the production of free
fatty acids with antibacterial properties. Free fatty acids can be
released from lipids by the hydrolytic action of enzymes and have
been shown to possess a diverse range of biological activities,
including antibacterial properties.48 Indeed, free fatty acids are
thought to play an important role in the innate immune system,
defending against potential pathogens particularly in the skin
and mucous membranes.49 The exact mechanism of the antimi-
crobial action of free fatty acids remains unclear; however, the
main target appears to be the cell membrane. There has been a
suggestion that free fatty acids may disrupt the electron transport
chain or interfere with oxidative phosphorylation, or may lead to
increased fluidity of the membrane which can ultimately lead to
instability and cell lysis.48 Moreover in a recent study it has been
shown that specific fatty acids can inhibit the growth of Staphylo-
coccus aureus by disrupting the cytoplasmic membrane which
allows metabolites and low
molecular weight proteins to
leak from the cell.50 Thus
the AbgT protein may act
by releasing fatty acids that
lead to disruption of the cell
membrane in B. subtilis
DSM10, resulting in cell
death. Another alternative is
that the AbgT protein may
function in a similar manner
to a putative lipase which
the Brady group have
recently isolated following
the functional screening of a
Ralstonia metallidurans
hosted soil metagenomic
library.37 They propose that
the anti B. subtilis activity
displayed by this putative
lipase may result from its
ability to cleave ester bonds
present in the bacterial cell
wall.
While the generation of
antibacterial free fatty acids
is a plausible explanation for
the inhibition of the growth
of B. subtilis DSM10 it
should also be noted that a
recent study discovered 2
novel esterases from a soil
metagenome that were capable of reactivating the antibiotic
activity of chloramphenicol from its acetylated derivatives formed
by the action of chloramphenicol acetyl tranferases.51 As chlor-
amphenicol was present in the media and the B. subtilis DSM10
strain was sensitive to this antibiotic, the AbgT protein may pro-
duce a similar effect. However there was no sequence similarity
between AbgT and the 2 esterases identified in the above study
and in addition, these esterases were members of the group IV
family of lipases rather than the VIII family.
In summary, the data suggests that the AbgT protein is
involved in growth inhibition of B. subtilis DSM10 and it seems
likely that the effects may be mediated by hydrolytic activity.
These results suggest not only that functional metagenomic based
approaches can provide a significant resource for the discovery of
novel functional proteins but that hydrolytic enzymes involved in
the release of free fatty acids may be a target for the development
of new biomedical therapies.
Materials and Methods
Sampling
Suppressive soil samples were collected from an organic field
trial site at the Teagasc Oak Park research facility (Co. Carlow,
Figure 5. Puriﬁcation of His6-AbgT protein. His6- AbgT was puriﬁed from the total soluble protein fraction of cell
lysate of E coli EPI300TM T1 transformed with the recombinant vector pBadMyc-HisA-AB-RH1. The expressed anti-
bacterial protein was puriﬁed from the supernatant by Ni-NTA spin column and resolved by SDS-PAGE on a 10%
gel. (A) Anti-bacillus activity of the puriﬁed Abg protein from cell lysate (1; puriﬁed fraction of Ni-NTA column, 2;
protein fraction from cell lysate, 3; supernatant fraction, 4; wash from Ni-NTA elution, 5; control with cell free lysate
from EP1300 cells). (B) Lane 1 stained with Invision His-tag In-gel stain showing the mass of the puriﬁed protein at
approximately 50 kDa. (C) Lane 1 showing the puriﬁed protein stained with Coomassie brilliant blue.
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Ireland; http://www.agresearch.teagasc.ie/oakpark/) that had
been in yearly crop rotation for 7 y and had only been fertilized
with organic farmyard manure and compost. Samples were taken
from a triticale field shortly after harvest. Bulk samples were
taken from the surface to a depth of approx. Ten cm using sterile,
DNA-free tools (treated with 5% sodium hypochlorite for
30 min prior to washing and autoclaving) and stored in sterile,
DNA-free plastic containers. Samples were transported to the
laboratory on ice, aseptically fractionated and stored at 4C until
further processing.
Extraction and purification of High Molecular Weight DNA
Metagenomic DNA was extracted from the soil as previously
described52 with the following modifications. Soil was sieved
through one stainless steel mesh (mesh size 4 mm). Fifteen grams
of freshly sieved soil was mixed with 20 ml preheated (70C)
lysis buffer in 50 ml tubes and incubated at 70C for 2 hours
with thorough mixing by hand every 30 min. After cooling for
30 min at room temperature, the tubes were centrifuged at 4000
£ g for 20 min at 4C and the supernatant was transferred to a
fresh tube. The soil pellet was re-suspended in fresh preheated
lysis buffer (20 ml) and the extraction procedure was repeated.
Supernatants from both extractions were pooled and DNA was
precipitated with 0.7 vol isopropanol at ¡20C overnight. Pre-
cipitated DNA was pelleted by centrifugation at 5000 £ g for
60 min at 4C and the pellet was washed once with 10 ml of
70% ethanol and air-dried. One ml of TE buffer (10 mM Tris-
HCl, 1 mM EDTA, pH8) was added to the pellet and the high-
molecular weight (HMW) DNA was dissolved slowly by incuba-
tion at 4C for several hours with gently regular agitation by
hand. The crude HMW-DNA was purified and size-separated by
pulsed-field gel electrophoresis (PFGE; at 6 V / cm, 1–25 switch
time, 120 angle, 17 hrs, 14C) in 0.5x TBE (45 mM Tris-HCl,
45 mM boric acid, 1 mM EDTA, pH 8.3) on a 1% PFGE grade
agarose gel (Bio-Rad Laboratories). For size comparison, each gel
contained a PFGE DNA Molecular marker (MidRange II PFG
Marker, New England Biolabs). The marker lane and approx.
0.5 cm of the sample DNA lane were cut off and stained for
30 min in 1x SYBR Safe dye (Invitrogen) for visualization. Two
gel-slices (approx. One cm) containing unstained DNA of about
30–50 kb and 50–70 kb were cut out and the DNA was electro-
Figure 6. Partial alignment of AbgT with related members of the family VIII group of lipases. The alignment includes; closely related putative b-lactamase
proteins from Turneriella parva, Asticcacaulis biprosthecum and Parvibaculum lavamentivorans; antibacterial protein from CcAb2; esterase and hydrolase
enzymes from uncultured bacteria (EstM-N2 and Lpc53E1), Burkholderia gladioli, Brevibacteroum linens and Gordonia sp; class C b-lactamases from Escher-
ichia coli and Enterobacter cloacae. Conserved sites S-X-X-K and Y are shaded. The numbers represent amino acids of the AbgT protein.
Table 2. Protein similarity searches for AbgT amino acid sequence
ORF % Identity Protein Organism E Value Swiss-Prot Accession No.
26 (abgT) 37 Uncharacterized protein Rv1367c/MT1414 Mycobacterium tuberculosis 6e-54 P9WLZ2 /P9WLZ3
34 Esterase EstB Burkholderia gladioli 2e-42 Q9KX40
30 UPF0214 protein YfeW Escherichia coli O157:H7 7e-31 Q8XBJ0
30 UPF0214 protein YfeW Escherichia coli strain K12 2e-30 P77619
29 UPF0214 protein YfeW Salmonella enteritidis PT4 2e-28 B5R4I5
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eluted out of the gel and concentrated as described by Brady52
with the following modifications: Electro-elution was performed
for 3 h with replacement of running buffer after 90 min; DNA
was concentrated to a final volume of approx. 100 ml with Viva-
Spin 6 (MWCO 50000) concentrators (Sartorius). Washed and
concentrated DNA was dislodged from the membranes by plac-
ing the filter upside-down in a clean 50 ml tube and centrifuging
for 5 min at 5000 £ g. Size and purity was checked by PFGE
with the conditions stated above. DNA concentration was deter-
mined using the NanoDrop ND-1000 spectrophotometer.
Construction of metagenomic fosmid library
HMW DNA was end-repaired and metagenomic libraries
were constructed using the CopyControlTM Fosmid Library Pro-
duction Kit pCC1FOS (Epicentre Biotechnologies), according
to the manufacturer’s instructions. Titers were calculated and
approximately 4000–5000 E. coli EPI300TM T1 fosmid clones
were plated onto 20 £ 20 cm Luria-Bertani (LB) agar supple-
mented with 12.5 mg/ml chloramphenicol. The clones were
picked with the Genetix Qpix2 XT robotic system (Molecular
Devices) into 384-well plates containing LB media with the fol-
lowing supplements: 6.3 g/l K2HPO4, 1.8g/l KH2PO4, 0.5 g/l
sodium citrate dihydrate, 0.09 g/l MgSO4.7H2O, 6% glycerol.
After incubation at 37C for 18 - 20 hrs, the libraries were stored
at -80C. Twelve clones from the HMW DNA library were ran-
domly picked for determination of average insert size. Isolated
fosmids were digested with NotI for 3–4 hr and analyzed by
Pulsed Field Gel Electrophoresis with the following conditions:
1% agarose in 0.5% TBE, 6 V/cm, 1–25 switch time, 120
angle, 11.5 hrs, 14C. Induction of the fosmid to multiple copies
was performed using 10% arabinose (filter sterilized). Fosmid
DNA was extracted using the GeneJETTM Plasmid Miniprep kit
(Fermentas) and DNA was eluted in 30 ml of water. To ensure
efficient library production the fosmid control DNA supplied
with the kit was also subjected to the same reaction conditions as
the isolated HMWDNA. E. coli EPI300TM T1 clones containing
pCC1FOS with cloned fosmid control DNA were subsequently
used as a control when screening the soil metagenomic libraries
for antimicrobial activities.
Screening of fosmid libraries for antimicrobial activities
Fosmid clones were replicated into fresh 384-well plates con-
taining LB medium, supplemented with 12.5 mg/ml chloram-
phenicol, and incubated at 37C overnight. The clones were
arrayed on 20 £ 20 cm agar plates containing LB medium,
12.5 mg/ml chloramphenicol and 0.01% arabinose using the
QPix2 XT robotic system. Plates were incubated at 37C over-
night, followed by further incubation at 25C for 3–5 d after
which the clones were exposed to UV light for 1 min and then
overlaid with soft (0.5%) agar containing the following test
strains: Pseudomonas aeruginosa PA01 and Bacillus subtilis
DSM10. P. aeruginosa PA01 and B. subtilis DSM10 were grown
to OD600 of approx. One.0 and 1.5 respectively and diluted 1:50
for B. subtilis DSM10 and 1:100 for P. aeruginosa PA01 in soft
LB agar before being carefully poured over the metagenomic
clones. The plates were incubated overnight and examined for
zones of growth inhibition.
Sequencing and annotation of fosmid
Fosmids were sequenced by Roche 454 pyrosequencing.
Sequencing and assembly were carried out by the University of
Liverpool, Center for Genomic Research. Contigs from the
assembly were analyzed for putative open reading frames
(ORFs) using the FGENESB-Bacterial Operon and Gene Pre-
diction Program (www.softberry.com) and the MetaGene pro-
gram.53 The Basic Local Alignment Search Tool (BLAST) at
NCBI (http://www.ncbi.nlm.nih.gov/BLAST) was used to
search DNA and protein databases for homologous DNA and
protein sequences.54 Potential ORFs were analyzed using blastP
searches against the non-redundant protein sequences database
and the SwissProt database. Conserved functional or structural
protein domains were identified using the Conserved Domain
Database at the NCBI (http://www.ncbi.nlm.nih.gov/Struc
ture/cdd/cdd.shtml).55 Sequences upstream of predicted start
codons were examined for the presence of bacterial promoters
using the BPROM-Prediction of Bacterial Promoters Program
(www.softberry.com). The theoretical parameters of putative
proteins were calculated using the ExPASy ProtParam tool.56
Protein sequences were also examined for signal peptides using
the SignalP 4.0 server.57 Multiple sequence alignments and
phylogenetic analyses were conducted using MEGA version 4.1
software.58 Evolutionary trees were constructed using the
Neighbor-Joining method with a bootstrap test of 1000 repli-
cates. Attempts were made to predict the potential phylogenetic
origin of the fosmid DNA using MEGAN.59
Transposon mutagenesis of fosmids
Fosmids were subjected to mutagenesis using the EZ-
Tn5TM<TET-1> Insertion kit (Epicentre Biotechnologies),
according to the manufacturer’s instructions. The mutant mini-
library was plated on LB medium containing 12.5 mg/ml chlor-
amphenicol and 10 mg/ml tetracycline. The clones were hand-
picked into liquid media in 96-well plates, incubated overnight
and subsequently replicated onto solid LB medium containing
12.5 mg/ml chloramphenicol and 0.01% arabinose to induce the
fosmids to multiple copies. The plates were then incubated over-
night at 37C, followed by 2 further overnight incubations at
25C and overlaid with the B. subtilis DSM10 as described
above. Mutants that appeared to have lost the ability to inhibit
growth were selected for further analysis. The insertion site of the
EZ-Tn5 transposon was mapped using bidirectional sequencing
with primers TET-1 FP-1 (50 GGG TGC GCA TGA TCC
TCT AGA GT 30) and TET-1 RP-1 (50 TAA ATT GCA CTG
AAA TCT AGA AAT A 30).
Detection of lipolytic and b-lactamase activities
Lipolytic activity was detected by plating the clones on LB
medium containing 1% tributyrin (Sigma-Aldrich). The plates
were incubated at 37C overnight, followed by further incuba-
tion at 25C for up to 7 d during which the plates were examined
regularly for zones of clearing. The chromogenic b-lactamase
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substrate nitrocefin (Calbiochem) was used to detect b-lactamase
activity. Briefly, a 1 mM working solution of nitrocefin was pre-
pared according to the manufacturer’s instructions. One drop of
the nitrocefin solution was placed directly on the surface of a col-
ony and the development of a red color was used as an indication
of a positive result. In addition the colonies were also tested for
activity by emulsifying the colony into one drop of the nitrocefin
solution on the surface of a glass slide.
Sub-cloning of the abgT gene and complementation of the
transposon mutant
The abgT gene was amplified from the fosmid TO-T 020 P12
using the primers AB-BL F Pag (50 TAT TAC TCA TGA CCG
CTG CGA ACT CAC TG 30) and AB-BL R IF Hind (50 ATC
ATT AAG CTT TCT TCC GTG GCG GAC 30). Restriction
sites were mis-primed (underlined above) into the 50 end of the
primers to allow insertion of the gene into the expression vector
pBadMyc-HisA (Invitrogen). The gene was inserted under the
control of the arabinose inducible PBAD promoter and the stop
codon of the open reading frame was removed to allow a C-ter-
minal fusion with the poly-histidine region of the vector. PCR
was performed using Pfu DNA polymerase and the PCR product
(»1.3 kb) was purified from a 1% agarose gel and subsequently
digested using the restriction enzymes PagI and HindIII at 37C
for 90 min. The pBadMyc-HisA vector was digested using NcoI
and HindIII using similar conditions. The digested products
were purified and ligated overnight at 16C with T4 DNA ligase
(Fermentas). E. coli EPI300TM T1 cells were transformed with
the ligation mixture and plated on LB medium containing
100 mg/ml carbenicillin. The presence of the insert was con-
firmed by colony PCR and restriction digestion. Transposon
mutant clones were subsequently transformed with the purified
recombinant vector.
Purification of His-tagged AbgT protein
E. coli EPI300TM T1 cells containing the recombinant pBad-
Myc-HisA vector were grown in LB medium containing
100 mg/ml carbenicillin until mid-log phase and then induced
with 0.01% arabinose for 4 h. The cells were harvested by centri-
fugation, re-suspended in lysis buffer (50 mM of NaH2PO4, 300
mM of NaCl, 10 mM imidazole, pH 8.0) and incubated on ice
for 20 minutes. Cells were then disrupted by sonication in ice
with 3 5 second pulses at high intensity and the supernatant was
collected after centrifugation. The His-tagged protein was puri-
fied by Ni-NTA spin column with varying concentration of
imidazole (20- 250 mM) used in the elution buffer to maximise
the amount of purified product in a single elute. The purified
protein was dialyzed and lyophilized before being resolved by
SDS–PAGE.
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